Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07483255 · ClinicalTrials.gov registry record · NA
A Phase II Trial of Fetal Embolization for Vein of Galen Malformation
A NA study, sponsored by Darren Orbach.
- Not yet
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07483255: Clinical Trial NA study, sponsored by Darren Orbach.
NCT07483255 is a NA study that has not yet begun recruiting, run by Darren Orbach. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07483255, a NA study, has not yet begun recruiting, sponsored by Darren Orbach.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a prospective, single-arm non-randomized interventional study of fetuses to assess the efficacy and safety of fetal embolization of VOGM. Subjects will receive a one-time study intervention of fetal embolization, at or after 34 weeks of gestation. After delivery, neurological assessments will be performed every 6 months for 2 years (adjusted for gestational age). Data will be compared to historical cohorts.
Primary Outcome
Primary outcome/endpoint: mortality measured from birth to day 30 of life.
Interventions
- DEVICE Fetal embolization of vein of Galen malformation using Target XL and XXL Detachable Coils
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-05 |
| Est. Completion | 2032-12 |
| Phase | NA |
What is known before NCT07483255 opens enrollment
NCT07483255 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Fetal embolization of vein of Galen malformation using Target XL and XXL Detachable Coils is the first listed.
NCT07483255 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07483255 about?
NCT07483255 is a clinical study titled "A Phase II Trial of Fetal Embolization for Vein of Galen Malformation". This is a prospective, single-arm non-randomized interventional study of fetuses to assess the efficacy and safety of fetal embolization of VOGM. Subjects will receive a one-time study intervention of fetal embolization, at or after 34 weeks of gestation. After delivery, neurological assessments wil...
What is the current status of trial NCT07483255?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-05. Estimated completion is 2032-12.
What interventions are being tested in trial NCT07483255?
The interventions under investigation include: Fetal embolization of vein of Galen malformation using Target XL and XXL Detachable Coils (DEVICE).
Who is sponsoring clinical trial NCT07483255?
This trial is sponsored by Darren Orbach, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07483255's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia